Value Sense
ALGN
Align Technology, Inc. (ALGN)
Last Price$175.1(6.4%)
Market Cap$13.6B
Intrinsic value score
6/10
Good
Intrinsic value
$190.0
DCF value - $88.0 Relative value - $292.0
Undervalued
8.5%
LTM P/E
32.2x
Peer set median 39.4x
Discount rate
11.0%
ALGN
is 8.5% undervalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

ALGN Intrinsic value

Key Highlights:
Relative Value vs Current Share Price
As of Mar 03, 2025 ALGN Relative Value is $304.1, which is undervalued by 73.7%, compared to current share price of $175.1.
DCF Value vs Current Share Price
As of Mar 03, 2025 ALGN DCF Value is $90.9, which is overvalued by 48.1%, compared to current share price of $175.1.
Methodology
Price per share, $
ALGN
Intrinsic value$190.0
Undervalued by8.5%
Current share price
175.1
Relative value
304.1
DCF value
90.9

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Low P/E stocks

Low P/E stocks

Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.

3M Return 7.5%
S&P Outperformance -5.5%
Next 3M Predicted Return 10.2%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%

ALGN Historical Intrinsic Value

Crunching data... Almost there!

ALGN vs Peer Set: Intrinsic Value Comparison

General

Intrinsic Value

Financials

Company name

Undervaluation/Overvaluation

Revenue growth

EPS growth

Net income margin

Align Technology, Inc. logo
Align Technology, Inc.ALGN
8.5%
3.4%
26.0%
11.5%
Median Peer Set
5.6%
126.3%
12.7%
Boston Scientific Corporation logo
Boston Scientific CorporationBSX
(67.4%)
17.6%
16.7%
11.1%
Insulet Corporation logo
Insulet CorporationPODD
(50.7%)
30.0%
4,364.6%
12.2%
DexCom, Inc. logo
DexCom, Inc.DXCM
(49.8%)
11.3%
(1.4%)
14.3%
Edwards Lifesciences Corporation logo
Edwards Lifesciences CorporationEW
(24.2%)
(9.4%)
202.2%
76.7%
Stryker Corporation logo
Stryker CorporationSYK
(22.7%)
10.2%
(5.8%)
13.2%
STERIS plc logo
STERIS plcSTE
(10.4%)
3.6%
257.9%
7.4%
Medtronic plc logo
Medtronic plcMDT
21.5%
3.6%
(2.1%)
11.4%
Abbott Laboratories logo
Abbott LaboratoriesABT
24.5%
4.6%
134.5%
31.9%
Zimmer Biomet Holdings, Inc. logo
Zimmer Biomet Holdings, Inc.ZBH
72.0%
6.5%
253.2%
13.8%
Koninklijke Philips N.V. logo
Koninklijke Philips N.V.PHG
146.8%
(0.8%)
118.1%
(3.9%)

Explore more intrinsic value tools hub for ALGN

DCF value calculator
Reverse DCF
Peter Lynch charts
Relative Value
Earnings growth model
Peter Lynch Fair Value
Margin of safety
Ben Graham Fair Value
Earnings Power Value
Discount rate

FAQ

What is Align Technology, Inc. intrinsic value?

As of Mar 03, 2025, Align Technology, Inc. Intrinsic Value is $190.0. This suggests it may be undervalued by 8.5% compared to its current price of around $175.1.

What is Align Technology, Inc. DCF (discounted cash flow) valuation?

As of Mar 03, 2025, Align Technology, Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at $90.9. This suggests it may be overvalued by 48.1% to its current price of around $175.1, using a discount rate of 11.0% and terminal growth rate of 3.0%.

Is Align Technology, Inc. overvalued or undervalued?

Align Technology, Inc. is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $190.0, compared to a market price of around $175.1. This suggests a potential undervaluation of 8.5%.